Related references
Note: Only part of the references are listed.M30, a brain permeable multi target neurorestorative drug in post nigrostriatal dopamine neuron lesion of parkinsonism animal models
Moussa B.H. Youdim
PARKINSONISM & RELATED DISORDERS (2015)
The role of iron as a mediator of oxidative stress in Alzheimer disease
Rudy J. Castellani et al.
BIOFACTORS (2012)
8-Substituted 3-Arylcoumarins as Potent and Selective MAO-B Inhibitors: Synthesis, Pharmacological Evaluation, and Docking Studies
Dolores Vina et al.
CHEMMEDCHEM (2012)
Molecular Insights into Human Monoamine Oxidase B Inhibition by the Glitazone Antidiabetes Drugs
Claudia Binda et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury
Nina Kaludercic et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors
Alexandra Gaspar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Controversies in Neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease
Matthias Loehle et al.
BMC NEUROLOGY (2011)
Monoamine reuptake inhibition and mood-enhancing potential of a specified oregano extract
Annis O. Mechan et al.
BRITISH JOURNAL OF NUTRITION (2011)
Towards the Discovery of a Novel Class of Monoamine Oxidase Inhibitors: Structure-Property-Activity and Docking Studies on Chromone Amides
Alexandra Gaspar et al.
CHEMMEDCHEM (2011)
Alzheimer's Disease: From Pathogenesis to Disease-Modifying Approaches
Daniela Galimberti et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2011)
The State of the Art of Pyrazole Derivatives as Monoamine Oxidase Inhibitors and Antidepressant/Anticonvulsant Agents
D. Secci et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives
Daniela Secci et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Interactions of Monoamine Oxidases with the Antiepileptic Drug Zonisamide: Specificity of Inhibition and Structure of the Human Monoamine Oxidase B Complex
Claudia Binda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Synthesis and Study of a Series of 3-Arylcoumarins as Potent and Selective Monoamine Oxidase B Inhibitors
Maria J. Matos et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Chromone, a Privileged Scaffold for the Development of Monoamine Oxidase Inhibitors
Alexandra Gaspar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Transcriptional regulation and multiple functions of MAO genes
Jean C. Shih et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
NOVEL MOLECULAR TARGETS OF THE NEUROPROTECTIVE/NEURORESCUE MULTIMODAL IRON CHELATING DRUG M30 IN THE MOUSE BRAIN
L. Kupershmidt et al.
NEUROSCIENCE (2011)
Insomnia, platelet serotonin and platelet monoamine oxidase in chronic alcoholism
Korona Nenadic Sviglin et al.
NEUROSCIENCE LETTERS (2011)
Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors
Franco Chimenti et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Investigations on the 2-thiazolylhydrazyne scaffold: Synthesis and molecular modeling of selective human monoamine oxidase inhibitors
Franco Chimenti et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors
Maria Joao Matos et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Chromone-2-and-3-carboxylic acids inhibit differently monoamine oxidases A and B
Stefano Alcaro et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
MAO inhibitors: Risks, benefits, and lore
Molly Wimbiscus et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2010)
Inhibition of monoamine oxidase by indole and benzofuran derivatives
Louis H. A. Prins et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Focusing on new monoamine oxidase inhibitors
Adriana Bolasco et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Propargylamine Containing Compounds as Modulators of Proteolytic Cleavage of Amyloid-beta Protein Precursor: Involvement of MAPK and PKC Activation
Orit Bar-Am et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Potentiation of Ligand Binding through Cooperative Effects in Monoamine Oxidase B
Daniele Bonivento et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Targeting monoamine oxidase A in advanced prostate cancer
Vincent Flamand et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Synthesis, Stereochemical Separation, and Biological Evaluation of Selective Inhibitors of Human MAO-B: 1-(4-Arylthiazol-2-yl)-2-(3-methylcyclohexylidene)hydrazines
Franco Chimenti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
The Novel Multifunctional, Iron-Chelating Drugs M30 and HLA20 Protect Pancreatic β-Cell Lines from Oxidative Stress Damage
Danit Mechlovich et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Reversible Inhibitors of Monoamine Oxidase-A (RIMAs): Robust, Reversible Inhibition of Human Brain MAO-A by CX157
Joanna S. Fowler et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Synthesis and selective inhibition of human monoamine oxidases of a large scaffold of (4,5-substituted-thiazol-2-yl)hydrazones
Franco Chimenti et al.
MEDCHEMCOMM (2010)
Molecular and Mechanistic Properties of the Membrane-Bound Mitochondrial Monoamine Oxidases
Dale E. Edmondson et al.
BIOCHEMISTRY (2009)
Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors
Maria Joao Matos et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors
Maria Joao Matos et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Synthesis, Molecular Modeling, and Selective Inhibitory Activity against Human Monoamine Oxidases of 3-Carboxamido-7-Substituted Coumarins
Franco Chimenti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
New considerations in the medical management of early Parkinson's disease: Impact of recent clinical trials on treatment strategy
Robert A. Hauser
PARKINSONISM & RELATED DISORDERS (2009)
Monoamine oxidase inactivation: From pathophysiology to therapeutics
Marco Bortolato et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome
Nurcan Ueceyler et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B
David M. Gooden et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
The selegiline transdermal system in major depressive disorder: A systematic review of safety and tolerability
Donald S. Robinson et al.
JOURNAL OF AFFECTIVE DISORDERS (2008)
Quantitative Structure-Activity Relationship and Complex Network Approach to Monoamine Oxidase A and B Inhibitors
Lourdes Santana et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Synthesis, stereochemical identification, and selective inhibitory activity against human monoamine oxidase-B of 2-methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones
Franco Chimenti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Increase of monoamine oxidase-B activity in the brain of scrapie-infected hamsters
Karim Tarik Adjou et al.
NEUROCHEMISTRY INTERNATIONAL (2008)
MAO-B Elevation in Mouse Brain Astrocytes Results in Parkinson's Pathology
Jyothi K. Mallajosyula et al.
PLOS ONE (2008)
Structure of human monoamine oxidase A at 2.2-Å resolution:: The control of opening the entry for substrates/inhibitors
Se-Young Son et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: Safinamide and coumarin analogs
Claudia Binda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Platelet monoamine oxidase activity in obsessive-compulsive disorder
Manuel Arrojo et al.
EUROPEAN PSYCHIATRY (2007)
Modelling the roles of MAO and SSAO in glucose transport
A. McDonald et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
New carbon-linked azole oxazolidinones with improved potency and pharmacokinetics
Sheila I. Hauck et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Recent advances in the development of hybrid molecules/designed multiple compounds with antiamnesic properties
Michael Decker
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2007)
Monoamine oxidase and tobacco dependence
A. Lewis et al.
NEUROTOXICOLOGY (2007)
Impact of species-dependent differences on screening, design, and development of MAO B inhibitors
Laura Novaroli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches
Marco Catto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity
M Yáñez et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
The therapeutic potential of monoamine oxidase inhibitors
MBH Youdim et al.
NATURE REVIEWS NEUROSCIENCE (2006)
A QSAR model for in silico screening of MAO-A inhibitors.: Prediction, synthesis, and biological assay of novel coumarins
L Santana et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Lipophilicity plays a major role in modulating the inhibition of monoamine oxidase B by 7-substituted coumarins
A Carotti et al.
CHEMISTRY & BIODIVERSITY (2006)
Recent development of monoamine oxidase inhibitors
A Bolasco et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2005)
Inhibition of monoamine oxidases by coumarin-3-acyl derivatives: biological activity and computational study
F Chimenti et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Evidence of oxidative damage in Alzheimer's disease brain:: central role for amyloid β-peptide
DA Butterfield et al.
TRENDS IN MOLECULAR MEDICINE (2001)
Share Paper
